Efecto terapéutico del tetramisol en la ascaridiasis
Abstract
El autor realiza un estudio sobre el efecto terapéutico del tetramisol en la ascaridiasis intestino!. Utiliza 60 pacientes a quienes les administra a dosis única según el siguiente esquema posológico: Menores de 1 año 15 cc. (64,95 mgs.), de 1 a 7 años 30 cc. (129,90 mgs.l y mayores de 7 años 2 tabletas (260 mgs.L Obtiene 81,66 % de cura parasicológica, valorada por la negativización en el recuento de huevos de Ascaris lumbricoides por gramo de heces, según la técnica de Stoll. Resalta las ventajas e importancia de la droga para el tratamiento individual y colectivo, así como, su posible aplicación en campañas epidemiológicas de control y erradicación de la Ascaridiasis intestinal.
Copyright (c) 2012 Susana Tarazón de Soto
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.
The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.
Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.